The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients

Vascular Health and Risk Management

Volumn 8, Issue 1, 2012, Pages 7-14

  Khafaji, Hadi Abdul Ridha Hadi ^a   Bener, Abdulbari ^b   Osman, Mohammed ^a   Al Merri, Ajayeb ^b   Al Suwaidi, Jassim ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Cardiac disease; Hs c reactive protein; Lipid profile; Ramadan fasting; Serum leptin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIACYLGLYCEROL; WARFARIN; CHOLESTEROL;

ADULT; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; BODY MASS; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH BELIEF; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RELEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELIGION; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VALVULAR HEART DISEASE; BODY WEIGHT; DIET; HEART DISEASE; MEDICAL RECORD; OUTPATIENT; RAMADAN;

ADULT; C-REACTIVE PROTEIN; CHOLESTEROL; FASTING; FEMALE; HEART DISEASES; HUMANS; ISLAM; LEPTIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84857069891     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S22894     Document Type: Article

References (41)

1. Sakr AH. Fasting in Islam. J Am Diet Assoc. 1975;67:17-21.
2. Azizi F. Medical aspects of Islamic fasting. Med J Islamic Rep Iran. 1996;10:241-246.
3. Al Suwaidi J, Bener A, Hajar HA, Numan MT. Does hospitalization for congestive heart failure occur more frequently in Ramadan: a population based study. Int J Cardiol. 2004;96(2):217-221.
4. Proceedings of the Second International Congress on Health and Ramadan; December 1-3, 1997; Istanbul, Turkey.
5. El-Hazmi MAF, Al-Faleh FZ, Al-Mofleh IB. Effect of Ramadan fasting on the values of hematological and biochemical parameters. Saudi Med J. 1987;8:171-176.
6. Gumaa KA, Mustafa KY, Mahmoud NA, et al. The effect of fasting in Ramadan. 1. Serum uric acid and lipid concentrations. Br J Nutr. 1978; 40(3):573-581.
7. Fedail SS, Murphy D, Salih SY, et al. Changes in certain blood constituents during Ramadan. Am J Clin Nutr. 1982;36:350-353.
8. Shoukry MI. Effect of fasting in Ramadan on plasma lipoproteins and apoproteins. Saudi Med J. 1986;7:561-565.
9. Hallak MH, Nomani MZA. Body weight loss and changes in blood lipid level in normal men on hypocaloric diets during Ramadan fasting. Am J Clin Nutr. 1988;8:1197-1210.
10. Zebrack JS, Muhlestein JB, Horne BD, et al. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol. 2002;39: 632-637.
11. Bogaty P, Poirier P, Simard S, et al. Biological profiles in subjects with recurrent acute coronary events compared with subjects with longstanding stable angina. Circulation. 2001;103:3062-3068.
12. Thompson SG, Kienast J, Pyke SDM, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635-641.
13. Nakanishi N, Shiraishi T, Wada M. Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Res Clin Pract. 2005;69(1):88-98.
14. Aronson D, Bartha P, Zinder O, et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med. 2004;21(1):39-44.
15. Pradhan AD, Cook NR, Buring JE, et al. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003;23(4):650-655.
16. Festa A, D'Agostino R Jr, Tracy RP, Hafner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med. 2002;19(11):939-943.
17. Sundell J, Huuppon R, Raitakari OT, Nuutila P, Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res. 2003;11(6):776-782.
18. Bodary PF, Westrick RJ, Wickenheiser KJ, et al. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA. 2002;287(13):1706-1709.
19. Piestrzeniewicz K, Luczak K, Komorowski J, Maciejewski M, Goch JH. The relationship between leptin and obesity and cardiovascular risk factors in men with acute myocardial infarction. Cardiol J. 2007;14(3):252-259.
20. Kazumi T, Kawaguchi A, Hirano T, et al. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism. 2003;52(9):1113-1116.
21. Al Suwaidi J, Bener A, Salam AM, et al. Does fasting alter the circadian pattern of acute cardiac events? J Postgrad Med. 2006;52:30-33.
22. Al Suwaidi J, Bener A, Hajar HA, et al. A population-based study of Ramadan fasting and acute coronary syndromes (1991-2001). Heart. 2004;90:695-696.
23. Al Suwaidi J, Zubaid M, Al Mahmeed WA, et al. Impact of fasting in Ramadan in patient with cardiac disease; a multi-center prospective study. Saudi Med J. 2005;26(10):1579-1583.
24. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem. 1996;42: 942-946.
25. Fridewald WF, Levy RI, Frederickson DS. Estimation of LDL-cholesterol concentration without use of the preparative ultra-centrifuge. Clin Chem. 1972;18:499-502.
26. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDLcholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002;48:236-254.
27. Boden G, Chen X, Kolaczynski JW, et al. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest. 1997;100:1107-1113.
28. Licinio J, Negrao AB, Mantzoros C, et al. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A. 1998;95:2541-2546.
29. Schoeller DA, Cella LK, Sinha MK, et al. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest. 1997;100: 1882-1887.
30. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92(4B):17K-22K.
31. Norusis MJ. SPSS/PC+ for Windows. Base System and Advanced Statistical User's Guide. Windows Version #12. Chicago, IL: SPSS Inc; 1998.
32. Perk G, Ghanem J, Aamar S, Ben-Ishay D, Bursztyn M. The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J Hum Hypertens. 2001;15:723-725.
33. Maislos M, Khamaysi N, Assali A, Abou-Rabiah Y, Zvili I, Shany S. Marked increase in plasma high-density lipoprotein cholesterol after prolonged fasting during Ramadan. Am J Clin Nutr. 1993;57:60-62.
34. Maislos M, Abou-Rabiah Y, Zuili I, Iordash S, Shany S. Gorging and plasma HDL-cholesterol: the Ramadan model. Eur J Clin Nutr. 1998;52:127-130.
35. Adlouni A, Ghalim N, Benslimane A, Lecery JM, Saile R. Fasting during Ramadan induces a marked increase in HDL and decrease in LDL-cholesterol. Ann Nutr Metab. 1997;1:22-29.
36. Temizhan A, Tandogan I, Donderici O, et al. The effects of Ramadan fasting on blood lipid levels. Am J Med. 2000;109:341-342.
37. Kassab S, Abdul Ghafar T, Nagalla S, et al. Interaction between leptin, neuropeptide-Y and insulin with chronic diurnal fasting during Ramadan. Ann Saudi Med. 2004;24(5):345-349.
38. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
39. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391-397.
40. Rutter MK, Meigs JB, Sullivan LM, et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004;110:380-385.
41. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 1999;84:1018-1022.